These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34280142)

  • 1. La Crosse Virus Disease in the United States, 2003-2019.
    Vahey GM; Lindsey NP; Staples JE; Hills SL
    Am J Trop Med Hyg; 2021 Jul; 105(3):807-812. PubMed ID: 34280142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007.
    Haddow AD; Bixler D; Odoi A
    BMC Infect Dis; 2011 Jan; 11():29. PubMed ID: 21269495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographically persistent clusters of La Crosse virus disease in the Appalachian region of the United States from 2003 to 2021.
    Day CA; Odoi A; Trout Fryxell R
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011065. PubMed ID: 36656896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007.
    Haddow AD; Odoi A
    PLoS One; 2009 Jul; 4(7):e6145. PubMed ID: 19582158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent spatial clustering and predictors of pediatric La Crosse virus neuroinvasive disease risk in eastern Tennessee and western North Carolina, 2003-2020.
    Day CA; Odoi AO; Moncayo A; Doyle MS; Williams CJ; Byrd BD; Trout Fryxell RT
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012186. PubMed ID: 38843214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinvasive arboviral disease in the United States: 2003 to 2012.
    Gaensbauer JT; Lindsey NP; Messacar K; Staples JE; Fischer M
    Pediatrics; 2014 Sep; 134(3):e642-50. PubMed ID: 25113294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. La Crosse virus neuroinvasive disease - Missouri, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(28):869-71. PubMed ID: 20651642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity.
    Boutzoukas AE; Freedman DA; Koterba C; Hunt GW; Mack K; Cass J; Yildiz VO; de Los Reyes E; Twanow J; Chung MG; Ouellette CP
    Clin Infect Dis; 2023 Feb; 76(3):e1114-e1122. PubMed ID: 35607778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. La Crosse Virus in Aedes japonicus japonicus mosquitoes in the Appalachian Region, United States.
    Harris MC; Dotseth EJ; Jackson BT; Zink SD; Marek PE; Kramer LD; Paulson SL; Hawley DM
    Emerg Infect Dis; 2015 Apr; 21(4):646-9. PubMed ID: 25811131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. La Crosse virus encephalitis in children.
    Ouellette CP
    Curr Opin Infect Dis; 2024 Oct; 37(5):419-424. PubMed ID: 39079177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The demographic and socioeconomic factors predictive for populations at high-risk for La Crosse virus infection in West Virginia.
    Haddow AD; Bixler D; Schuh AJ
    PLoS One; 2011; 6(9):e25739. PubMed ID: 21980533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly recognized focus of La Crosse encephalitis in Tennessee.
    Jones TF; Craig AS; Nasci RS; Patterson LE; Erwin PC; Gerhardt RR; Ussery XT; Schaffner W
    Clin Infect Dis; 1999 Jan; 28(1):93-7. PubMed ID: 10028077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative sequence analyses of La Crosse virus strain isolated from patient with fatal encephalitis, Tennessee, USA.
    Lambert AJ; Fryxell RT; Freyman K; Ulloa A; Velez JO; Paulsen D; Lanciotti RS; Moncayo A
    Emerg Infect Dis; 2015 May; 21(5):833-6. PubMed ID: 25898269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of La Crosse Virus in North America and Potential for Future Spread.
    Goldman T; Hamer DH
    Am J Trop Med Hyg; 2024 May; 110(5):850-855. PubMed ID: 38531108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. La Crosse virus neuroinvasive disease: the kids are not alright.
    Day CA; Byrd BD; Trout Fryxell RT
    J Med Entomol; 2023 Nov; 60(6):1165-1182. PubMed ID: 37862102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. La Crosse Virus Circulation in Virginia, Assessed via Serosurveillance in Wildlife Species.
    Faw LR; Riley J; Eastwood G
    Infect Dis Rep; 2023 Jun; 15(4):360-369. PubMed ID: 37489390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible congenital infection with La Crosse encephalitis virus--West Virginia, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):4-7. PubMed ID: 19145220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for West Nile Virus Disease - United States, 2009-2018.
    McDonald E; Mathis S; Martin SW; Staples JE; Fischer M; Lindsey NP
    MMWR Surveill Summ; 2021 Mar; 70(1):1-15. PubMed ID: 33661868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
    Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
    J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
    Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.